The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Clopidogrel MSN 75 mg film-coated tablets



MSN Labs Europe LimitedPA23250/005/001

Main Information

Trade NameClopidogrel MSN 75 mg film-coated tablets
Active SubstancesClopidogrel Hydrogen Sulfate
Dosage FormFilm-coated tablet
Licence HolderMSN Labs Europe Limited
Licence NumberPA23250/005/001

Group Information

ATC CodeB01AC04 clopidogrel

Status

License statusAuthorised
Licence Issued05/01/2024
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back